276 related articles for article (PubMed ID: 17445466)
1. [To improve the survival rate of patients suffering from locally advanced non-small cell lung cancer with combination of radiotherapy and chemotherapy].
Zhu GY
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):88-90. PubMed ID: 17445466
[No Abstract] [Full Text] [Related]
2. [Neoadjuvant therapy of stage III non-small cell lung cancer].
Hara N; Ohta M
Kyobu Geka; 1991 Dec; 44(13):1114-20. PubMed ID: 1661792
[TBL] [Abstract][Full Text] [Related]
3. [What is the value of neoadjuvant therapy in bronchial carcinoma?].
Digel W; Brethner L; Hasse J
Zentralbl Chir; 2000; 125(4):315-8. PubMed ID: 10829310
[TBL] [Abstract][Full Text] [Related]
4. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
Bunn PA
Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
[TBL] [Abstract][Full Text] [Related]
5. Treatment of non-small-cell lung cancer: the Chinese experience in a general teaching hospital.
Chen YM; Chao JY; Tsai CM; Shiau CY; Liang MJ; Yen SH; Perng RP
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):459-66. PubMed ID: 10925536
[TBL] [Abstract][Full Text] [Related]
6. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
8. Combined modality therapy of non-small cell lung cancer.
Ruckdeschel JC
Semin Oncol; 1997 Aug; 24(4):429-39. PubMed ID: 9280223
[TBL] [Abstract][Full Text] [Related]
9. [Bronchial cancer--development, diagnosis, therapy, prognosis].
Zöchbauer S; Krajnik G; Huber H
Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of the cumulative survival curve of unresectable non-small cell lung cancers (NSCLC) in stage I-III after radiotherapy].
Morita K; Fuwa N; Uchiyama Y
Gan No Rinsho; 1990 Feb; 36(2):135-41. PubMed ID: 2155332
[TBL] [Abstract][Full Text] [Related]
11. Multimodality therapy for non-small-cell lung cancer.
Lilenbaum RC; Green MR
Oncology (Williston Park); 1994 May; 8(5):25-31; discussion 32, 35-6. PubMed ID: 8025004
[TBL] [Abstract][Full Text] [Related]
12. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
[TBL] [Abstract][Full Text] [Related]
13. Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.
Rizzo S
Oncol Rep; 1998; 5(3):667-71. PubMed ID: 9538173
[TBL] [Abstract][Full Text] [Related]
14. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of non-resectable stage III non-small cell lung cancer].
Fournel P
Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S43-7. PubMed ID: 15536352
[TBL] [Abstract][Full Text] [Related]
16. [Recent issues in the treatment of advanced non-small-cell lung cancer].
Negoro S
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations on the therapy of bronchial carcinoma].
Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
[No Abstract] [Full Text] [Related]
18. A phase II trial of induction chemotherapy followed by continuous hyperfractionated accelerated radiotherapy in locally advanced non-small-cell lung cancer.
Jenkins P; Anderson S; Wronski S; Ashton A
Radiother Oncol; 2009 Dec; 93(3):396-401. PubMed ID: 19435642
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors and therapeutic strategy in non-small-cell bronchial carcinoma].
Wolf M
Praxis (Bern 1994); 1997 Oct; 86(42):1640-6. PubMed ID: 9432685
[TBL] [Abstract][Full Text] [Related]
20. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
